DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival

Thomas Fleischer , Jovana Klajic , Miriam Ragle Aure , Riku Louhimo , Arne Pladsen , Lars Ottestad , Nizar Touleimat (1) , Marko Laakso , Ann Rita Halvorsen , Grethe Alnæs , Margit L.H. Riis , Åslaug Helland , Sampsa Hautaniemi , Per Eystein Lønning , Bjorn Naume (2) , Anne-Lise Børresen-Dale (3) , Jörg Tost (4) , Vessela Kristensen

1 IBISC - Informatique, Biologie Intégrative et Systèmes Complexes
2 TNRH - The Norwegian Radium Hospital [Oslo, Norway]
3 UiO - University of Oslo
4 Laboratory for Epigenetics and Environment

Domaines: Statistiques [stat]; Machine Learning [stat.ML]; Applications [stat.AP]; Sciences du Vivant [q-bio]; Biologie cellulaire; Biochimie, Biologie Moléculaire; Bio-Informatique, Biologie Systémique [q-bio.QM]; Génétique; Cancer; Médecine humaine et pathologie

Thomas Fleischer, Jovana Klajic, Miriam Ragle Aure, Riku Louhimo, Arne Pladsen, et al.. DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. Oncotarget, 2017, 8 (1), ⟨10.18632/oncotarget.13718⟩. ⟨cea-01833188⟩